• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片受体选择性肽的结构比较证实了生物活性的四个参数。

Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity.

机构信息

Institute of Biochemistry, Biological Research Center of the Hungarian Academy of Sciences, 62 Temesvári körút, Szeged H-6720, Hungary.

出版信息

J Mol Graph Model. 2010 Feb 26;28(6):495-505. doi: 10.1016/j.jmgm.2009.11.006. Epub 2009 Dec 3.

DOI:10.1016/j.jmgm.2009.11.006
PMID:20036591
Abstract

Structural determinants of binding to the mu-opioid receptor, an important target in analgesia, attract great scientific attention. Many natural and synthetic peptides and peptidomimetics were shown previously to bind to this receptor selectively but there is no consensus about the structure responsible for biological activity. No high resolution structure of this receptor is available and the binding site of ligands is not exactly known. However, mu-opioid ligands with similar affinity and selectivity should possess at least one common structural feature. Comparative structural analysis of such ligands, considering adequate representation of binding conditions, may reveal key features of bioactivity. In this study ten mu-opioid receptor ligands, DAMGO, Tyr-W-MIF-1, morphiceptin, endomorphin-1 and 2 and their analogues, possessing different affinity and selectivity, were examined using molecular dynamics. Conformational preference of these molecules was determined in H(2)O and DMSO along with structural properties previously proposed to be important for binding. Four of such structural requirements were confirmed to be important, providing a possible structural model of receptor binding. Simultaneous fulfillment of these requirements results most likely in high affinity binding to the mu-opioid receptor.

摘要

与μ-阿片受体结合的结构决定因素,是镇痛的一个重要靶点,引起了极大的科学关注。先前已经表明,许多天然和合成肽和肽模拟物可以选择性地与该受体结合,但对于负责生物活性的结构尚无共识。该受体没有高分辨率结构,配体的结合位点也不完全清楚。然而,具有相似亲和力和选择性的μ-阿片受体配体应该至少具有一个共同的结构特征。考虑到结合条件的充分代表性,对这些配体进行比较结构分析,可以揭示生物活性的关键特征。在这项研究中,使用分子动力学研究了十个μ-阿片受体配体,包括 DAMGO、Tyr-W-MIF-1、吗啡肽、内吗啡肽-1 和 2 及其类似物,它们具有不同的亲和力和选择性。在 H(2)O 和 DMSO 中确定了这些分子的构象偏好,以及以前被认为对结合很重要的结构特性。确认了其中四个结构要求很重要,为受体结合提供了一个可能的结构模型。这些要求的同时满足很可能导致与μ-阿片受体的高亲和力结合。

相似文献

1
Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity.阿片受体选择性肽的结构比较证实了生物活性的四个参数。
J Mol Graph Model. 2010 Feb 26;28(6):495-505. doi: 10.1016/j.jmgm.2009.11.006. Epub 2009 Dec 3.
2
A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.对μ阿片样物质配体结合选择性至关重要的阿片受体结构域的嵌合分析。
Neurobiol Dis. 1996 Feb;3(1):87-96. doi: 10.1006/nbdi.1996.0009.
3
A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.δ-阿片受体的单个残基Lys108可阻止μ-阿片选择性配体[D-Ala2,N-MePhe4,Gly-ol5]脑啡肽与δ-阿片受体结合。
Mol Pharmacol. 1996 Nov;50(5):1413-22.
4
Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.对δ-阿片受体具有高选择性的4-(N,N-二芳基氨基)哌啶的合成与评价:3D-QSAR和配体对接联合研究
Drug Des Discov. 2000;17(1):34-50.
5
Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.阿片肽受体研究。7. 甲基芬太尼同系物RTI-4614-4及其四种对映体与大鼠μ阿片受体的不同结构域结合。
Synapse. 1998 Feb;28(2):117-24. doi: 10.1002/(SICI)1098-2396(199802)28:2<117::AID-SYN2>3.0.CO;2-E.
6
Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.[二甲基色胺转运体1](Dmt1)DALDA与DAMGO在μ、δ和κ阿片受体结合及G蛋白激活方面的比较。
J Pharmacol Exp Ther. 2003 Dec;307(3):947-54. doi: 10.1124/jpet.103.054775. Epub 2003 Oct 8.
7
Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.在第二和第三跨膜结构域中保守天冬氨酸处结合有机和无机阳离子的μ-阿片受体同源模型。
Arch Biochem Biophys. 2000 Mar 1;375(1):31-49. doi: 10.1006/abbi.1999.1529.
8
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.构象受限强啡肽A类似物的合成与阿片样活性。2. “靶向”序列中的构象限制。
J Med Chem. 1997 Apr 11;40(8):1211-8. doi: 10.1021/jm960753p.
9
Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries.从两个合成组合文库中鉴定出六种高活性的μ-选择性阿片肽。
Pept Res. 1995 May-Jun;8(3):124-37.
10
Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.新型神经介素B受体拮抗剂——取代生长抑素类似物的发现
Mol Pharmacol. 1993 Oct;44(4):841-50.

引用本文的文献

1
Evidencing the role of a conserved polar signaling channel in the activation mechanism of the μ-opioid receptor.证明一个保守的极性信号通道在μ-阿片受体激活机制中的作用。
Comput Struct Biotechnol J. 2025 Jul 16;27:3216-3228. doi: 10.1016/j.csbj.2025.07.014. eCollection 2025.
2
Design and Pharmacological Characterization of αβ Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism.αβ 整合素环肽激动剂的设计与药理学特性:激动剂与拮抗剂配体决定因素的计算研究。
J Med Chem. 2023 Apr 13;66(7):5021-5040. doi: 10.1021/acs.jmedchem.2c02098. Epub 2023 Mar 28.
3
Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.
肽模拟物及其在阿片肽药物发现中的应用。
Biomolecules. 2022 Sep 5;12(9):1241. doi: 10.3390/biom12091241.
4
Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β-Lysine.含β-赖氨酸的环状阿片肽类似物的合成、药理评价和计算研究。
Molecules. 2021 Dec 28;27(1):151. doi: 10.3390/molecules27010151.
5
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation.µ-阿片受体激动剂的药理学特征具有偏向 G 蛋白或β-arrestin 信号转导,以及受体激活过程中构象变化的计算研究。
Molecules. 2020 Dec 22;26(1):13. doi: 10.3390/molecules26010013.
6
Mexneurin is a novel precursor of peptides in the central nervous system of rodents.Mexneurin是啮齿动物中枢神经系统中一种新型的肽前体。
FEBS Lett. 2017 Jun;591(12):1627-1636. doi: 10.1002/1873-3468.12679. Epub 2017 Jun 1.
7
Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics.苯丙氨酸(3)-苯丙氨酸(4)修饰的内吗啡肽-2拟肽的结构与生物学研究
ACS Med Chem Lett. 2013 Jul 11;4(8):795-9. doi: 10.1021/ml400189r. eCollection 2013 Aug 8.
8
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues.内吗啡肽-2 杂合类似物的合成、药理学评价及构象研究。
Mol Divers. 2013 Feb;17(1):19-31. doi: 10.1007/s11030-012-9399-5. Epub 2012 Nov 4.
9
Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells.荧光肽-PNA 嵌合体用于成像神经元细胞中单胺氧化酶 A mRNA。
Bioconjug Chem. 2012 Feb 15;23(2):158-63. doi: 10.1021/bc2004507. Epub 2012 Jan 25.
10
Stereochemical basis for a unified structure activity theory of aromatic and heterocyclic rings in selected opioids and opioid peptides.某些阿片类药物和阿片肽中芳香环与杂环统一构效关系理论的立体化学基础
Perspect Medicin Chem. 2010 Feb 18;4:1-10. doi: 10.4137/pmc.s3898.